Curaleaf Holdings (CURLF) Other Non-Current Assets (2019 - 2025)

Curaleaf Holdings (CURLF) recorded quarterly Other Non-Current Assets of $12.0 million in Q4 2025, little changed quarter-over-quarter from $12.0 million in Q4 2024, and little changed on a YoY basis from $12.0 million in Q4 2024.

Curaleaf Holdings (CURLF) Other Non-Current Assets (2019 - 2025) Analysis & Trends

Curaleaf Holdings' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $12.0 million for Q4 2025.

  • In Q4 2025, Other Non-Current Assets changed 0.0% year-over-year to $12.0 million; the TTM figure through Dec 2025 stood at $12.0 million (changed 0.0% YoY), while the FY2025 annual figure was $12.0 million, changed 0.0% from the prior year.
  • Other Non-Current Assets was $12.0 million for Q4 2025 at Curaleaf Holdings, roughly flat from $12.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $46.8 million in Q2 2023 to a low of -$34.3 million in Q3 2022.
  • Historically, Other Non-Current Assets has averaged $9.9 million across 5 years, with a median of $8.6 million in 2023.
  • The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets surged 1958.42% in 2021, then tumbled 249.85% in 2022.
  • A 5-year view of Other Non-Current Assets shows it stood at $6.7 million in 2021, then jumped by 132.29% to $15.5 million in 2022, then tumbled by 44.37% to $8.6 million in 2023, then surged by 39.53% to $12.0 million in 2024, then changed by 0.0% to $12.0 million in 2025.
  • The last three Other Non-Current Assets figures came in at $12.0 million (Q4 2025), $12.0 million (Q4 2024), and $8.2 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.79 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 351.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 233.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 73.60 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 295.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 59.36 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 47.63 Mn
10 Curaleaf Holdings - - 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 12.00 Mn
Dec 31, 2024 12.00 Mn
Sep 30, 2024 8.16 Mn
Jun 30, 2024 9.11 Mn
Dec 31, 2023 8.60 Mn
Sep 30, 2023 3.57 Mn
Jun 30, 2023 46.79 Mn
Dec 31, 2022 15.46 Mn
Sep 30, 2022 -34.28 Mn
Jun 30, 2022 3.74 Mn
Mar 31, 2022 3.58 Mn
Dec 31, 2021 6.66 Mn
Sep 30, 2021 22.88 Mn
Jun 30, 2021 24.71 Mn
Mar 31, 2021 5.99 Mn
Dec 31, 2020 35.14 Mn
Sep 30, 2020 5.54 Mn
Jun 30, 2020 -1.44 Mn
Mar 31, 2020 291,000.00
Dec 31, 2019 8.83 Mn